Document is current
Any future updates will be listed below
-
Authors
Amorim, João A. http://orcid.org/0000-0002-7720-6264
Coppotelli, Giuseppe http://orcid.org/0000-0002-6067-001X
Rolo, Anabela P. http://orcid.org/0000-0003-3535-9630
Palmeira, Carlos M.
Ross, Jaime M. http://orcid.org/0000-0002-3879-4817
Sinclair, David A. http://orcid.org/0000-0002-9936-436X
- License Information
-
More Information
Article History
Accepted: 17 December 2021
First Online: 10 February 2022
Competing interests
: D.A.S. is a founder, equity owner, advisor to, director of, board member of, consultant to, investor in and/or inventor on patents licensed to Revere Biosensors, UpRNA, GlaxoSmithKline, Wellomics, DaVinci Logic, InsideTracker (Segterra), Caudalie, Animal Biosciences, Longwood Fund, Catalio Capital Management, Frontier Acquisition Corporation, AFAR (American Federation for Aging Research), Life Extension Advocacy Foundation (LEAF), Cohbar, Galilei, EMD Millipore, Zymo Research, Immetas, Bayer Crop Science, EdenRoc Sciences (and affiliates Arc-Bio, Dovetail Genomics, Claret Bioscience, MetroBiotech, Astrea, Liberty Biosecurity and Delavie), Life Biosciences, Alterity, ATAI Life Sciences, Levels Health, Tally (aka Longevity Sciences) and Bold Capital. D.A.S. is an inventor on a patent application filed by Mayo Clinic and Harvard Medical School that has been licensed to Elysium Health. The other authors declare no competing interests.
